ki-67 score is the core protein expressed at G1, S, G2, and M phases of tumor cells and a solid tumor proliferation marker being associated with prognosis of breast carcinoma (BC) and its response to neoadjuvant chemotherapy [3]. This evidence concerns the gene MKI67 and breast cancer.